WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 11,93 | 11,93 | 2020-09-30 |
| Nordnet Pensionsförsäkring | 6,50 | 6,50 | 2020-09-30 |
| Kjell Stenberg | 3,03 | 3,03 | 2020-09-30 |
| Tommy Andersson | 2,05 | 2,05 | 2020-09-30 |
| Gunvald Berger | 1,52 | 1,52 | 2020-09-30 |
| Lars-Erik Forsgårdh | 1,33 | 1,33 | 2020-09-30 |
| Linfan Zhang | 0,90 | 0,90 | 2020-09-30 |
| Nils Qvarner | 0,59 | 0,59 | 2020-09-30 |
| Robert Joki | 0,57 | 0,57 | 2020-09-30 |
| Livförsäkringsbolaget Skandia | 0,55 | 0,55 | 2020-09-30 |
2021-02-08 Bokslutskommuniké 2020
2021-05-06 Årsstämma 2020
2021-05-06 Delårsrapport 2021-Q1
2021-08-19 Delårsrapport 2021-Q2
2021-11-18 Delårsrapport 2021-Q3
2022-02-24 Bokslutskommuniké 2021